Nilotinib induces deeper molecular responses vs continued imatinib in patients with ph+ chronic myeloid leukemia (CML) with detectable disease after ≥ 2 years on imatinib: ENESTcmr 12-months results
Author: Cervantes, C..  v. 97  no. Supp 1, pp. 239  Date: 2012
ISSN:  0390-6078,  DOI:   
Get full text via these sources:
Any issues, please contact the library for help: